Healx Logo

Work with us

Partnerships that power new rare disease treatments

True medical breakthroughs happen when industry, patient groups and academic institutions work together. Let’s collaborate to accelerate the development of novel treatments for rare diseases

Whilst cutting-edge AI technology is integral to our work, we couldn’t have achieved as much as we have done to date without the involvement of our partners. We welcome enquiries from groups interested in partnering with us to progress treatments for rare diseases.

Card image

Patient groups

Working together, we can discover and develop new treatments for your rare disease - fast.

Card image

Academic groups

By collaborating, we can progress therapies towards the clinic and on to commercialisation.

Card image

Biotech and pharma

Together, we de-risk the drug discovery process and drive forward novel and effective treatments.

Partnerships

Ways of working together

Icon

The Rare Treatment Accelerator

Our Rare Treatment Accelerator (RTA) options or licenses academic, patient, and industry group drug redevelopment projects focused on rare diseases.

By combining our team, expertise and financial resources with your research and insights, we can get treatments to patients faster.

Learn more

Icon

Healx pipeline

We work across a range of rare disease areas and have a number of treatments progressing towards the clinic. We welcome enquiries both from groups whose diseases of interest fit with our current portfolio, along with those from groups working on other rare conditions where relevant assets, resources and data are available.

Learn more

Our technology

Our AI leverages its unique dataset to predict novel connections in biomedical data, de-risk the opportunities and progress the most promising candidates toward the clinic.

About Healx

We’re a next-generation team of drug hunters, AI engineers and bioinformaticians, all working together to accelerate the discovery of new treatments for rare diseases.